Legacy Ventures International (LGYV) 10-Q 15 May 20 2020 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Mar. 31, 2020	May 15, 2020
Document and Entity Information [Abstract]
Entity Registrant Name	LEGACY VENTURES INTERNATIONAL INC.
Entity Central Index Key	0001616788
Amendment Flag	false
Current Fiscal Year End Date	--06-30
Document Type	10-Q
Document Period End Date	Mar. 31, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Entity File Number	333-199040
Is Entity a Shell Company?	false
Entity Small Business	true
Is Entity an Emerging Growth Company	false
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Entity Interactive Data Current	Yes
Entity Incorporation, State or Country Code	NV
Entity Common Stock, Shares Outstanding		315,064

INTERIM CONDENSED BALANCE SHEET

INTERIM CONDENSED BALANCE SHEETS (Unaudited) - USD ($)	Mar. 31, 2020	Jun. 30, 2019
Current assets
Cash	$ 19,267	$ 12,745
Total assets	19,267	12,745
Current liabilities
Accounts payable and accrued liabilities	76,001	82,764
Secured promissory notes	100,000	50,000
Convertible notes	20,000	20,000
Interest payable	8,797	3,651
Advances from third parties	22,925	22,925
Total liabilities	227,723	179,340
Stockholders' deficiency
Preferred Stock, $0.0001 par value; 10,000,000 shares authorized: Preferred Stock - no shares issued and outstanding March 31, 2020 and June 30, 2019	0	0
Common Stock, $0.0001 par value; 100,000,000 shares authorized: 315,064 shares issued and outstanding September 30, 2019 and June 30, 2019	32	32
Additional paid in capital	6,394,771	6,394,771
Accumulated deficit	(6,603,259)	(6,561,398)
Total stockholders' deficiency	(208,456)	(166,595)
Total liabilities and stockholders' deficiency	$ 19,267	$ 12,745

INTERIM CONDENSED BALANCE SHE_2

INTERIM CONDENSED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares	Mar. 31, 2020	Jun. 30, 2019
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	315,064	315,064
Common stock, shares outstanding	315,064	315,064

INTERIM CONDENSED STATEMENTS OF

INTERIM CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Operating expenses
Professional fees	$ 9,750	$ 15,850	$ 31,350	$ 37,100
Other general and administration	372	833	3,570	6,014
Loss from operations	(10,122)	(16,683)	(34,920)	(43,114)
Other (expenses) income
Gain on cancellation of convertible note	0	0	0	545,580
Interest expense - Convertible and Secured notes	(3,091)	(712)	(5,146)	(30,899)
Accretion expense - Convertible notes	0	0	0	(467,575)
Bank charges and other	(1,795)	0	(1,795)	(30)
Total other (expenses) income	(4,886)	(712)	(6,941)	47,076
(Loss) Income before taxes	(15,008)	(17,395)	(41,861)	3,962
Net (loss) income and comprehensive (loss) income	$ (15,008)	$ (17,395)	$ (41,861)	$ 3,962
Net (loss) income per share - basic	$ (0.05)	$ (0.06)	$ (0.13)	$ 0.01
Net (loss) income per share - diluted	$ (0.05)	$ (0.06)	$ (0.13)	$ 0.01
Weighted average number of common shares outstanding - basic	315,064	315,064	315,064	315,064
Weighted average number of common shares outstanding - diluted	315,064	315,064	315,064	341,731

INTERIM CONDENSED STATEMENTS _2

INTERIM CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIENCY) (Unaudited) - USD ($)	Common Stock	Additional Paid-In Capital	Deficit	Total
Beginning balance at Jun. 30, 2018	$ 32	$ 6,394,771	$ (6,536,554)	$ (141,751)
Beginning balance, shares at Jun. 30, 2018	315,064
Net Loss			3,962	3,962
Ending balance at Mar. 31, 2019	$ 32	6,394,771	(6,532,592)	(137,789)
Ending balance, shares at Mar. 31, 2019	315,064
Net Loss			(28,806)	(28,806)
Ending balance at Jun. 30, 2019	$ 32	6,394,771	(6,561,398)	(166,595)
Ending balance, shares at Jun. 30, 2019	315,064
Net Loss			(41,861)	(41,861)
Ending balance at Mar. 31, 2020	$ 32	$ 6,394,771	$ (6,603,259)	$ (208,456)
Ending balance, shares at Mar. 31, 2020	315,064

INTERIM CONDENSED STATEMENT OF

INTERIM CONDENSED STATEMENT OF CASH FLOWS (Unaudited) - USD ($)	9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash used in operating activities
Net (loss) income	$ (41,861)	$ 3,962
Adjustments to reconcile net loss to net cash used by operating activities:
Gain on cancellation of convertible note	0	(545,580)
Accretion expense - Debt discount on convertible promissory note	0	467,575
Changes in non-cash operating assets and liabilities
Interest payable - Convertible notes	5,146	30,899
Accounts payable and accrued liabilities	(6,763)	25,349
Net cash used in operating activities	(43,478)	(17,795)
Cash flow from financing activities
Proceeds from secured convertible note	50,000	50,000
Net cash provided by financing activities	50,000	50,000
Increase in cash	6,522	32,205
Cash, beginning of period	12,745	30
Cash, end of period	19,267	32,235
Cash payments for Interest	0	0
Cash payments for Income taxes	$ 0	$ 0

ORGANIZATION AND DESCRIPTION OF

ORGANIZATION AND DESCRIPTION OF BUSINESS	9 Months Ended
	Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND DESCRIPTION OF BUSINESS	NOTE 1 - ORGANIZATION AND DESCRIPTION OF BUSINESS Legacy Ventures International, Inc. (“Legacy” or the “Company”), was incorporated on March 4, 2014 under the laws of the State of Nevada The Company currently has no ongoing operations except for the incurring of general and administrative expenditures. Previously, since September 15, 2015, the Company operated through a wholly-owned subsidiary RM Fresh Brands Inc. (“RM Fresh”). On August 31, 2016, in order to fund the ongoing operation and further development of RM, the Company consented to new third party investments into RM in the approximate total amount of $175,000, made in the form of cash and retirement of indebtedness owed by RM. As result of these new investments into RM, the Company’s ownership percentage of the RM Fresh was reduced to twenty percent (20%). The Company entered into a mutual Release agreement with RM. Under the Release, the Company released and discharged all liabilities owed to the Company by RM (with the exception of the Demand Promissory Note). RM in turn released the Company of all liabilities owing to RM and released the Company all ongoing contractual and financial responsibilities to RM, including the Company’s contractual obligation to further fund management fees or other expenses to be incurred by RM. The carrying value of the investment in RM Fresh was previously written down to $nil. On June 28, 2017, Randall Letcavage entered into a stock purchase agreement for the acquisition of an aggregate of 286,720 shares of Common Stock of the Company, representing approximately 91% of the issued and outstanding shares of Common Stock of the Company as of such date, from Rehan Saeed, the previous majority shareholder of the Company (the “Purchase Agreement”). The Purchase Agreements were fully executed and delivered, and the transaction consummated as of and at July 7, 2017. Consequently, Mr. Letcavage was able to unilaterally control the election the Company’s Board of Directors, all matters upon which shareholder approval is required and, ultimately, the direction of the Company. In addition, on June 28, 2017, Rehan Saeed submitted his resignation from all executive officer positions with the Company, including Chief Executive Officer and President, effective on the 10th day following the filing of a Schedule 14f-1 with the U.S. Securities and Exchange Commission. On June 28, 2017, Randall Letcavage was appointed as Chief Executive Officer, Chief Financial Officer, Director, effective immediately. On June 28, 2017, the Company entered into a non-binding letter of intent to enter into a business combination with Nexalin Technology, Inc., a Nevada corporation (“Nexalin”). On June 6, 2018, the Company reported that Matthew Milonas entered into an agreement for the acquisition of an aggregate of 286,720 shares of Common Stock of the Company, representing approximately 91% of the issued and outstanding shares of Common Stock of the Company (the “Shares”) as of such date, from Randall Letcavage, the majority shareholder of the Company (the “Agreement”). However, Mr. Milonas claims that he did not fully execute and deliver the Agreement and has disclaimed ownership of the subject shares. Mr. Letcavage will not contest Mr. Milonas’ claims and as a result, Mr. Letcavage’s ownership of the shares did not change as disclosed. On August 9, 2018, Mr. Letcavage, as the holder of 91% of the outstanding shares of common stock of the Company, approved the appointment of Peter Sohn as the Chief Executive Officer and Chief Financial Officer and Director of the Company. Effective December 17, 2018, Mr. Sohn accepted the appointments as Chief Executive Officer and Chief Financial Officer and Director of the Company. On December 17, 2018, Mr. Letcavage delivered to Peter Sohn an agreement for the acquisition by Mr. Sohn of the Shares from Mr. Letcavage, which agreement is dated August 9, 2018, but was delivered and deemed effective on December 17, 2018 (the “Agreement”). As a result, Mr. Sohn is now able to unilaterally control the election of our Board of Directors, all matters upon which shareholder approval is required and, ultimately, the direction of the Company. Effective September 11, 2017 (the “Closing Date”), the Company entered into a Share Exchange Agreement (the “Share Exchange Agreement”), dated as of September 1, 2017, by and among the Company, Nexalin and shareholders of Nexalin holding a majority of the issued and outstanding shares of Nexalin common stock (the “Nexalin Shareholders”). Pursuant to the Share Exchange Agreement, the Company agreed to exchange the outstanding equity stock of Nexalin held by the Nexalin Shareholders for units (the “Units”) consisting of an aggregate of approximately 25,000,000 newly issued shares of the Common Stock, $0.001 par value, and warrants (the “Warrants”) to purchase an aggregate of approximately 25,000,000 newly issued shares of the Common Stock, $0.001 par value, of the Company. The warrants are two-year warrants exercisable at the end of the first year for exercise prices between $1.50 and $1.75 per share, payable in cash. The warrants must be promptly exercised, and subject to forfeiture if not so exercised, if the Company’s shares achieve a trading price of $3.00 or more for 30 consecutive days. At the Closing Date, the Company approved the issuance of approximately 15,500,000 shares of common stock to the Nexalin shareholders, together with warrants for the purchase of an additional 15,500,000 shares and reserved approximately 9,500,000 additional shares, together with the related warrants, for the issuance to remaining Nexalin shareholders who are expected to execute and deliver the Share Exchange Agreement, including approximately 1,100,000 shares and related warrants issuable immediately to consultants in connection with the transactions contemplated by the Share Exchange Agreement. On September 15, 2017, the Company, filed a Current Report on Form 8-K (the “09/15/17 Form 8K”) announcing that effective September 11, 2017 (the “Closing Date”), the Company, and Nexalin, and shareholders of Nexalin holding a majority of the issued and outstanding shares of Nexalin common stock (the “Nexalin Shareholders”), on the other hand, entered into a Share Exchange Agreement (the “Share Exchange Agreement”), dated as of September 1, 2017. On November 29, 2017, the Company filed an amendment to its 09/15/17 Form 8-K (the “11/29/17 Amended Form 8K”) announcing that the “Closing Date” as defined in the Share Exchange Agreement was September 30, 2017, and, further, as of the date of November 29, 2017, Amended Form 8K, the holders of approximately 90% of the equity securities of Nexalin had exchanged their shares into shares of the Company’s Common Stock. On December 26, 2017, the Company filed a Current Report on Form 8K (the “12/26/17 Form 8K”) announcing that on December 21, 2017, the Company’s sole officer and director, Randy Letcavage, who was at the time Nexalin’s sole officer and director, resigned all officer and director positions with the Company and Nexalin. It was also announced that Mark White was appointed as the Interim Chief Executive Officer and Interim Chief Financial Officer of both the Company and Nexalin. Finally, it was announced that Rick Morad was appointed as the sole director of the Company and Nexalin. On February 1, 2018, the Company filed a Current Report on Form 8K (the “02/01/18 Form 8K”) announcing that Mark White was appointed as a Company director.

GOING CONCERN AND BASIS OF PRES

GOING CONCERN AND BASIS OF PRESENTATION	9 Months Ended
	Mar. 31, 2020
Going Concern [Abstract]
GOING CONCERN AND BASIS OF PRESENTATION	NOTE 2 – GOING CONCERN AND BASIS OF PRESENTATION The Company’s interim condensed financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. During the current year, the Company has incurred recurring losses from operations and as at March 31, 2020, has a working capital deficiency of $208,456, and an accumulated deficit of $6,603,259. The Company’s continued existence is dependent upon its ability to continue to execute its operating plan and to obtain additional debt or equity financing. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. There can be no assurance that the necessary debt or equity financing will be available, or will be available on terms acceptable to the Company, in which case the Company may be unable to meet its obligations. Should the Company be unable to realize its assets and discharge its liabilities in the normal course of business, the net realizable value of its assets may be materially less than the amounts recorded in the unaudited interim condensed financial statements. The unaudited interim condensed financial statements do not include any adjustments relating to the recoverability of recorded asset amounts that might be necessary should the Company be unable to continue in existence. The unaudited interim condensed financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission, and should be read in conjunction with the audited financial statements and notes thereto contained in the Company's annual report filed with the SEC on Form 10-K for the year ended June 30, 2019. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein. Operating results for the three and nine months ended March 31, 2020 are not necessarily indicative of the results to be expected for the year ending June 30, 2020. Notes to the interim condensed financial statements which would substantially duplicate the disclosures contained in the audited financial statements for the year ended June 30, 2019, as reported in Form 10-K, have been omitted.

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES AND RECENT ACCOUNTING PRONOUNCEMENTS	9 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
SIGNIFICANT ACCOUNTING POLICIES AND RECENT ACCOUNTING PRONOUNCEMENTS	NOTE 3 – SIGNIFICANT ACCOUNTING POLICIES AND RECENT ACCOUNTING PRONOUNCEMENTS SIGNIFICANT ACCOUNTING POLICIES The Company's significant accounting policies have not changed from the year ended June 30, 2019. BASIC AND DILUTED NET INCOME (LOSS) PER SHARE The Company follows ASC Topic 260 to account for the loss per share. Basic earnings (loss) per common share ("EPS") calculations are determined by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the year. Diluted earnings (loss) per common share calculations are determined by dividing net income (loss) by the weighted average number of common shares and dilutive common share equivalents (if dilutive) outstanding. All dilutive common share equivalents were anti-dilutive for the three and nine months ended March 31, 2020 and the three months ended March 31, 2019. Diluted earnings per share and weighted average common shares outstanding – diluted, for the nine months ended March 31, 2019, reflects the conversion of the Unsecured Promissory Notes

SECURED PROMISSORY AND CONVERTI

SECURED PROMISSORY AND CONVERTIBLE NOTES	9 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
SECURED PROMISSORY AND CONVERTIBLE NOTES	NOTE 4 – SECURED PROMISSORY AND CONVERTIBLE NOTES CONVERTIBLE PROMISSORY NOTE On September 11, 2017, the Company issued a Convertible Promissory Note ("Convertible Note") to an accredited investor. The Convertible Note has an aggregate principal amount of $500,000, and was payable on September 11, 2018 (the "Maturity Date"), and bears an interest rate of 4% per annum, with an interest rate of 18% per annum if the Convertible Note was not repaid by the Maturity Date. The holder may convert the Convertible Note at any time up to the Maturity Date into shares of the Company's common stock, par value $0.001 per share, at a conversion price equal to $1.00 per share. The Company could prepay the Convertible Note prior to the Maturity Date and/or the date of conversion without penalty upon receiving the written consent of the holder. Interest expense for the three and nine months ended March 31, 2020, was $nil. Interest expense for the three months ended March 31, 2019 was $nil and $29,580, for the nine months ended March 31, 2019. The Convertible Note payable contained a beneficial conversion feature. As a result, the Company recognized a nominal value for the Convertible note, at the September 11, 2017 issuance date, the balance of which was accreted to the face value at the effective interest rate. Accretion expense for the nine months ended March 31, 2020 and 2019 was $nil and $467,575, respectively. The difference between the nominal value ascribe to the Convertible Note on issuance and the face value was recorded in the Additional Paid In Capital. As a result of the series of events discussed previously on Note 1, on April 11, 2018, the Company wrote-off the value of the Convertible Note as well as the accrued interest receivable thereon. The Convertible Note was assigned to an accredited arm’s length third party, in exchange for the waiver of the promissory note payable pursuant to the terms of the Assignment Agreement. On September 11, 2017, the Company received a Promissory Note ("Promissory Note") from Nexalin Technology, Inc. The Promissory Note has an aggregate principal amount of $500,000 and is payable on December 31, 2017 (the "Maturity Date") and bears an interest rate of 4% per annum. On December 18, 2018, the Company entered into an assignment agreement (“Assignment Agreement”) with the holder of the Convertible Note, whereby, the Promissory Note was assigned to the Convertible Note holder in exchange for the waiver and cancellation of the Convertible Note. As a result, the Company recognized a gain of $545,580 for the year ended June 30, 2019, which was the carrying value of the Convertible Note and the accrued interest payable thereon at the time the assignment agreement was entered into. SECURED PROMISSORY NOTES On December 2, 2018, the Company issued a Secured Promissory Note ("Secured Notes") to an accredited investor. The Secured Note has an aggregate principal amount of $50,000, and is payable on December 2, 2019 (the "Maturity Date"), and bears an interest rate of 4% per annum and reverts to 18% after the Maturity Date. The amount owing under the Secured Note is secured by the assets of the Company. The note may be converted, the terms of which are to be negotiated between the Company and the note holder. The principal and interest was not paid at the maturity date as the Company continues to negotiate a settlement with the Secured Note holder. The Company has incurred interest expense of $2,365 and $493 for the three months ended March 31, 2020 and 2019, respectively, and incurred interest expense of $3,675 and $652 for the nine months ended March 31, 2020 and 2019, respectively. On September 6, 2019, the Company issued a Secured Promissory Note ("Secured Notes") to an accredited investor. The Secured Note has an aggregate principal amount of $50,000, and is payable on September 6, 2020 (the "Maturity Date"), and bears an interest rate of 4% per annum. The amount owing under the Secured Note is secured by the assets of the Company. The note may be converted, the terms of which are to be negotiated between the Company and the note holder. The Company recorded interest expense of $495 for the three months ended March 31, 2020 and $781 for the nine months ended March 31, 2020. UNSECURED CONVERTIBLE PROMISSORY NOTES On June 28, 2017 the Company issued $20,000 of unsecured convertible promissory notes (“Notes”). The Notes matured on June, 27, 2018, and bear interest at a rate of 8% per annum. The Notes are convertible into the Common Stock of the Company at a fixed conversion rate of $0.75 per share at any time prior to the maturity date. The Company evaluated the terms and conditions of the Notes under the guidance of ASC 815, Derivatives and Hedging. The conversion feature met the definition of conventional convertible for purposes of applying the conventional convertible exemption. The definition of conventional contemplates a limitation on the number of shares issuable under the arrangement. The instrument was convertible into a fixed number of shares and there were no down round protection features contained in the contracts. The Company was required to consider whether the hybrid contracts embodied a beneficial conversion feature (“BCF”). The calculation of the effective conversion amount resulted in a BCF because the fair value of the conversion was greater than the Company’s stock price on the date of issuance and a BCF was recorded in the amount of $20,000 and accordingly the amount of $20,000 was credited to Additional Paid in Capital. The BCF which represents debt discount is accreted over the life of the loan using the effective interest rate. Accretion expense for the three and nine months ended March 31, 2020 and 2019 was $nil, respectively. Interest expense for the three months ended March 31, 2020 and 2019, was $231 and $219, respectively. Interest expense for the three months ended March 31, 2020 and 2019 was $231 and $219, respectively. Interest expense for the nine months ended March 31, 2020, and 2019, was $691 and $668, respectively. As at March 31, 2020, the carrying value of the notes were $20,000 (June 30, 2019 - $20,000). No amounts of principal and interest for the above mentioned notes have been paid to date.

RELATED PARTY ADVANCES AND BALA

RELATED PARTY ADVANCES AND BALANCES, AND ADVANCES FROM THIRD PARTIES	9 Months Ended
	Mar. 31, 2020
Related Party Transactions [Abstract]
RELATED PARTY ADVANCES AND BALANCES, AND ADVANCES FROM THIRD PARTIES	NOTE 5 – RELATED PARTY ADVANCES AND BALANCES, AND ADVANCES FROM THIRD PARTIES During the three and nine months ended March 31, 2020 and 2019, the Company was advanced $nil, respectively, by a third party. The Company is currently in the process of negotiating with the third party with respect to settlement of the amount advanced. As at March 31, 2020 and June 30, 2019, the Advances from third parties was $22,925. The Company does not have any contractual maturity date nor interest obligations with respect to the Advances.

COMMON AND PREFERRED STOCK TRAN

COMMON AND PREFERRED STOCK TRANSACTIONS	9 Months Ended
	Mar. 31, 2020
Equity [Abstract]
COMMON AND PREFERRED STOCK TRANSACTIONS	NOTE 6 - COMMON AND PREFERRED STOCK TRANSACTIONS COMMON STOCK - AUTHORIZED As at March 31, 2020, the Company was authorized to issue 10,000,000 of preferred stock, with a par value of $0.0001 and 100,000,000 of common stock, with a par value of $0.0001. There were no common stock transactions in the period ended March 31, 2020 and year ended June 30, 2019.

SIGNIFICANT ACCOUNTING POLICI_2

SIGNIFICANT ACCOUNTING POLICIES AND RECENT ACCOUNTING PRONOUNCEMENTS (Policies)	9 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
BASIC AND DILUTED NET INCOME (LOSS) PER SHARE	BASIC AND DILUTED NET INCOME (LOSS) PER SHARE The Company follows ASC Topic 260 to account for the loss per share. Basic earnings (loss) per common share ("EPS") calculations are determined by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the year. Diluted earnings (loss) per common share calculations are determined by dividing net income (loss) by the weighted average number of common shares and dilutive common share equivalents (if dilutive) outstanding. All dilutive common share equivalents were anti-dilutive for the three and nine months ended March 31, 2020 and the three months ended March 31, 2019. Diluted earnings per share and weighted average common shares outstanding – diluted, for the nine months ended March 31, 2019, reflects the conversion of the Unsecured Promissory Notes

ORGANIZATION AND DESCRIPTION _2

ORGANIZATION AND DESCRIPTION OF BUSINESS (Details Narrative)	Jun. 06, 2018shares	Sep. 11, 2017Days$ / sharesshares	Jun. 28, 2017shares	Mar. 31, 2020shares	Jun. 30, 2019shares	Aug. 31, 2016USD ($)
Warrant term		2 years
Common stock, shares issued				315,064	315,064
Purchase of additional warrants, shares		15,500,000
Purchase of additional reserved warrants, shares		9,500,000
Trading price, per share | $ / shares		$ 3
Warrants issue, shares		1,100,000
Trading price number of consecutive days | Days		30
Warrant [Member] | Minimum [Member]
Exercise price of warrant | $ / shares		$ 1.50
Warrant [Member] | Maximum [Member]
Exercise price of warrant | $ / shares		$ 1.75
RM [Member]
Cash and retirement of indebtedness | $						$ 175,000
Randall Letcavage [Member] | Stock purchase agreement [Member]
Stock issued for acquisition			286,720
Percentage of issued and outstanding shares acquired			91.00%
Matthew Milonas [Member]
Stock issued for acquisition	286,720
Percentage of issued and outstanding shares acquired	91.00%
Nexalin Shareholder [Member]
Common stock, shares issued		15,500,000

GOING CONCERN AND BASIS OF PR_2

GOING CONCERN AND BASIS OF PRESENTATION (Details Narrative) - USD ($)	Mar. 31, 2020	Jun. 30, 2019
Going Concern [Abstract]
Working capital deficiency	$ (208,456)
Accumulated deficit	$ (6,603,259)	$ (6,561,398)

SECURED PROMISSORY AND CONVER_2

SECURED PROMISSORY AND CONVERTIBLE NOTES (Details Narrative) - USD ($)	Sep. 06, 2019	Dec. 02, 2018	Sep. 11, 2017	Jun. 28, 2017	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019	Jun. 30, 2019
Common stock, par value					$ 0.0001		$ 0.0001		$ 0.0001
Accretion expense					$ 0	$ 0	$ 0	$ 467,575
Gain on cancellation of Convertible Note					0	0	0	545,580	$ 545,580
Unsecured Convertible Promissory Notes [Member]
Aggregate principal amount				$ 20,000
Maturity date				Jun. 27, 2018
Interest-bearing, Interest Rate				8.00%
Interest expense					231	219	691	668
Accretion expense					0		0
Carrying value of convertible note					20,000		20,000		$ 20,000
Secured Promissory Note [Member]
Interest expense					2,365	493	3,675	652
Secured Promissory Note [Member] | Accredited investor [Member]
Aggregate principal amount		$ 500,000
Maturity date		Dec. 2, 2019
Interest-bearing, Interest Rate		4.00%
Convertible Promissory Note [Member]
Interest expense						$ 29,580	0	0
Convertible Promissory Note [Member] | Accredited investor [Member]
Aggregate principal amount			$ 500,000
Maturity date			Sep. 11, 2018
Interest rate			18.00%
Interest-bearing, Interest Rate			4.00%
Common stock, par value			$ 0.001
Conversion Price			$ 1
Accretion expense							0	$ 467,575
Convertible Note [Member] | Nexalin Technology, Inc [Member]
Aggregate principal amount			$ 500,000
Maturity date			Dec. 31, 2017
Interest-bearing, Interest Rate			4.00%
Secured Note [Member]
Interest expense					$ 495		$ 781
Secured Note [Member] | Accredited investor [Member]
Aggregate principal amount	$ 50,000
Maturity date	Sep. 6, 2020
Interest-bearing, Interest Rate	4.00%

RELATED PARTY ADVANCES AND BA_2

RELATED PARTY ADVANCES AND BALANCES, AND ADVANCES FROM THIRD PARTIES (Details Narrative) - USD ($)	9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Jun. 30, 2019
Related Party Transactions [Abstract]
Proceeds from third party advances	$ 0	$ 0
Advances from third parties	$ 22,925		$ 22,925

COMMON AND PREFERRED STOCK TR_2

COMMON AND PREFERRED STOCK TRANSACTIONS (Details Narrative) - $ / shares	Mar. 31, 2020	Jun. 30, 2019
Equity [Abstract]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	10,000,000	10,000,000
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	100,000,000	100,000,000